Course
Diabetic Kidney Disease
Course Highlights
- In this Diabetic Kidney Disease course, we will learn about signs and symptoms that may indicate diabetic kidney disease.
- You’ll also learn signs and symptoms that may indicate diabetic kidney disease.
- You’ll leave this course with a broader understanding of three risk factors of developing diabetic kidney disease.
About
Contact Hours Awarded: 1
Course By:
Kasee Wiesen, DNP, APRN, FNP-C
Begin Now
Read Course | Complete Survey | Claim Credit
➀ Read and Learn
The following course content
Introduction
Diabetes is an epidemic in the United States, with 1.2 million Americans diagnosed with diabetes each year, and in 2023, 11.6% of Americans had diabetes. People with diabetes are at a greater risk of developing many different chronic health problems including diabetic retinopathy, cardiovascular disease and chronic kidney disease. In the United States, diabetes is the leading cause of diabetic nephropathy or chronic kidney disease [1].
Due to the increased prevalence of diabetes and diabetic kidney disease, nurses and other healthcare professionals need to have a strong understanding of diabetes and the impact it can have on their patient’s well-being. And, with diabetes being the leading cause of chronic kidney disease, it is essential that health professionals can define diabetic kidney disease, explain assessment findings that support a diagnosis, and educate patients and family members on how to manage the chronic condition.
Definition
What is Diabetes?
Before we can discuss diabetic kidney disease, you must understand diabetes and how it impacts the body. Most of our food breaks down into sugar, also known as glucose, and is released into our bloodstream for energy. Insulin is a hormone produced by the pancreas that helps manage your blood sugar (the amount of sugar in your blood). As your blood sugar increases, your pancreas will release insulin, which helps regulate the amount of glucose released into the bloodstream.
With diabetes, your body does not make enough insulin or use the insulin properly, leading to increased glucose in the bloodstream. This process differentiates people with type 1 diabetes from Type 2 diabetes (National Kidney Foundation).
What is Diabetic Kidney Disease?
Diabetic kidney disease can occur when blood sugars are elevated and uncontrolled. Hyperglycemia can cause the vessels in the kidney to become narrow and clogged, reducing blood flow. Over time, this decrease in blood flow can damage the kidneys (National Kidney Foundation).
Diabetic kidney disease is a form of chronic kidney disease. It is broken down into five stages, indicating the degree of damage to the kidney based on the glomerular filtration rate (GFR) [4].
- Stage 1 (GFR 90 or greater): Kidney work as well as normal
- Stage 2 (GFR 60-89): Mild kidney disease and kidneys still work well
- Stage 3a (GFR 45-59): Mild to moderate kidney disease. Kidneys are not working as well as they should
- Stage 3b (GFR 30-44): Moderate to severe kidney disease. Kidneys are not working as well as they should
- Stage 4 (GFR 15-29): Severe kidney disease. Kidneys are barely working
- Stage 5 (GFR less than 15): The most severe type of kidney disease, often referred to as end-stage kidney disease. Kidneys are very close to not working or have failed.
Self Quiz
Ask yourself...
- What stage is considered end-stage kidney disease?
- How does hyperglycemia lead to kidney disease?
- What is the purpose of insulin?
Epidemiology
Diabetes is the leading cause of chronic kidney disease and end-stage kidney disease both in the United States and worldwide. The number of people diagnosed with diabetes in the United States has increased over the last 20 years from six to eleven percent. Of those with diabetes, it is estimated that 25 to 30 percent have chronic kidney disease. While over a fourth of people with diabetes have chronic kidney disease, less than 60% of these people are aware of their chronic kidney disease. Even more concerning, the prevalence of end-stage kidney disease more than doubled from 2000 to 2019 to nearly 800,000—and as of 2019, almost 40% or more than 307,000 people in the United States had end-stage kidney disease primarily caused by diabetes [13].
Risk Factors
Being able to identify patients at risk and providing education early on regarding diabetic kidney disease and steps to help prevent or slow down the progression is essential. Below is a list of modifiable and non-modifiable risk factors associated with diabetes and the development of diabetic kidney disease [13].
Age
Advancing age is directly related to the development of diabetic kidney disease. This is most likely since the older you are, the more likely you have had a greater exposure to diabetes, which is associated with progressive kidney disease. This may be due to the natural age-related changes in the kidney, which can lead to chronic kidney disease for many reasons [13].
Ancestry/Ethnicity
African Americans, Hispanic Americans, and American Indian populations have higher rates of albuminuria, decreased eGFR, and end-stage kidney disease when compared with white populations. The incidence of diabetic end-stage kidney disease is estimated at
- African Americans: 409 cases per 100,000 diabetic persons
- Hispanic Americans: 307 cases per 100,000 diabetic persons
- White Americans: 266 cases per 100,000 diabetic persons
These rates may be declining among white patients, but there may be a rise among the Mexican American population [13].
Sex
Diabetic kidney disease is more common in men than women [13].
Low Socio-Economic Status
Diabetic kidney disease is more common in people with lower education levels and those who live below the poverty level—and social determinants of health play a factor in this [13].
Obesity
You are six times more likely to develop type II diabetes if you are obese compared to those who are at a normal weight [2][13][18].
Smoking
There is a higher risk of developing kidney disease in those who smoke compared to those who do not smoke [13].
Hypertension
Hypertension increases the risk of kidney damage. Consistent systolic blood pressure of greater than 140mmHg increases the risk of developing albuminuria and chronic kidney disease [13] [3].
Self Quiz
Ask yourself...
- What are two modifiable risk factors of diabetic kidney disease?
- What are two non-modifiable risk factors of diabetic kidney disease?
- What disease process is the leading cause of kidney disease in the United States?
Pathophysiology
The pathophysiology of diabetic kidney disease is complex and multifactorial. It occurs due to a critical metabolic impairment involving the upstream influence of hyperglycemia, which leads to a dysregulated intracellular metabolism, inflammatory lesions, increased apoptosis processes, and tissue fibrosis. Three steps occur at the foundational level leading to diabetic kidney disease, which include:
- Glomerular hypertrophy leading to hyperfiltration
- Glomerular and tubulointerstitial inflammation related to chemokines, cytokines, and profibrotic factors activation
- Dysregulated cellular apoptosis and changes in the extracellular matrix
These three steps lead to the thickening of the glomerular basement, podocyte depletion, mesangial matrix expansion, and tubular damage. These factors contribute to the progression of diabetic kidney disease through vascular remodeling, endothelial dysfunction, glomerulosclerosis, and tubulointerstitial fibrosis [10].
When looking at diabetic kidney disease specifically, it begins with glomerular hyperinflation, which is in the early stages of renal injury and mild hypertension. The glomerular filtration rate (GFR) is normal but will worsen over time, decreasing GFR. Next, microalbuminuria is typically seen in a range of 30-300 mg albumin/day—the term microalbuminuria is used because detecting protein in the urine is difficult unless the albumin level is greater than 300 mg/day. Nephrotic syndrome occurs when albumin level, or proteinuria, exceeds 3 grams/day, and this often occurs approximately 3-5 years before end-stage kidney disease [10].
Urinary tract abnormalities such as papillary necrosis, type IV renal tubular acidosis, and urinary tract infections may also occur with diabetic kidney disease, leading to a faster decline of kidney function [10].
Clinical Signs and Symptoms
Often, people in the early stages of chronic kidney disease or diabetic kidney disease do not experience any symptoms. It is not until a person is in stage IV kidney disease that symptoms typically start to develop. Below are a few signs and symptoms people with diabetic kidney disease may experience.
- High blood pressure that gets harder to control
- Swelling of feet, ankles, hands or eyes
- Foamy urine
- Confusion or difficulty thinking
- Shortness of breath.
- Loss of appetite
- Nausea and vomiting
- Itching
- Tiredness and weakness
- Increased or decreased urine output
Because these symptoms are nonspecific and may be associated with many other problems, it is important to have your kidney function routinely assessed if you have diabetes [5].
Self Quiz
Ask yourself...
- What stage of kidney disease is an individual typically in before showing signs of diabetic kidney disease?
- What are three possible signs of diabetic kidney disease?
Assessment Findings
Patients with diabetes should be tested for diabetic kidney disease routinely because too many do not experience any symptoms until the disease is advanced. Type 2 diabetics should be tested for diabetic kidney disease yearly, and once type 1 diabetics who have had diabetes for more than five years should be tested annually [13].
Hemoglobin A1C (Hgb A1C)
Hemoglobin (Hgb) A1C is a blood test used to diagnose diabetes. A Hgb A1C of 6.5% or greater is considered a positive test for diabetes, and a Hgb A1C between 5.7% and 6.4% indicates prediabetes. Once diagnosed with diabetes, you should have your Hgb A1C checked every three months or 91 days, as this test is used to monitor how well a person’s diabetes is managed [8] [13].
Decrease Glomerular Filtration Rate (GFR)
The GFR is a lab test that shows how quickly and efficiently the kidneys can filter the blood. A GFR of 60 or greater is considered normal, a GFR between 15 and 60 indicates kidney disease, and a GFR of 15 or less indicates kidney failure. These levels are monitored closely in people with diabetes as it is a strong indicator of how well a person’s kidneys are functioning and if their diabetic kidney disease is progressing [13][16].
Persistent Albuminuria
Albumin is a protein found in the blood, and albuminuria is the presence of albumin in the urine. A healthy kidney does not allow albumin to pass from the blood to the urine, so when albumin is seen in the urine, it is often a marker of either an injury or damage to the kidney. A normal albumin level in your urine is less than 30mg/g—so anything more than this may suggest kidney disease even if your GFR is normal.
Albuminuria is not a requirement to diagnose a person with diabetic kidney disease, but it is often seen in those with diabetic kidney disease [13][15].
Albumin/Creatinine Ratio
If the albumin level is abnormal or elevated on your microalbumin creatinine ratio urine test, it could mean that you have kidney disease. Your family practice provider or endocrinologist can trend this level yearly to determine if your kidney disease is worsening. Higher levels of albumin in your urine can also indicate that you are at a greater risk of developing heart and vascular problems [12].
However, this test is not diagnostic as you can have an abnormal microalbumin creatinine ratio test for other problems such as a urinary tract infection or hepatitis [12].
Self Quiz
Ask yourself...
- What is one assessment finding that may indicate an individual has diabetic kidney disease?
- What is the GFR range that indicates kidney disease?
- What are three possible signs of diabetic kidney disease?
- When albumin is found in the urine, what does this indicate?
- What is the minimum length of time that should pass between assessments of kidney function in an individual with type 2 diabetes?
Treatment and Self-Management
There is no cure for diabetic kidney disease, but there are ways to help prevent further damage to the kidney or slow down the progression [17].
Control Your Blood Sugar
Management of blood sugar is one of the best ways to prevent or slow down kidney damage. This includes monitoring your hemoglobin A1C every three months and keeping a blood sugar log per the direction of your healthcare provider. Diabetes management is achieved through diet, exercise, and medications such as insulin or pills that help lower and stabilize blood sugar levels [17].
Control Your Blood Pressure
Blood pressure management is important in preventing and slowing down kidney disease. Hypertension, or uncontrolled high blood pressure, can lead to scarring of the kidneys, which impairs how the kidneys filter the blood and regulate fluid and electrolytes. Subsequently, the more damage done to the kidneys, the more difficult it may be to manage high blood pressure. Therefore, discussing your target blood pressure goal with your healthcare provider and how to achieve it best (AHA, American kidney specialists) is important [3][17].
Monitoring Cholesterol Levels
Managing cholesterol levels, including total cholesterol, LDL, and HDL, is important to minimize damage to larger blood vessels such as the brain or heart [17].
Take an ACE or ARB to Protect Kidney Function
Research has shown that certain blood pressure medications, specifically an ACE inhibitor (e.g., lisinopril) or an ARB (e.g., losartan), can slow down the loss of kidney function in those with diabetes. Diabetics can take these medications at a low dose for their kidney-protectant properties, even if they do not have hypertension [17].
Monitor Protein Intake
Consumption of protein is okay for those with diabetic kidney disease; it’s just important not to overeat it. Research has shown that eating less protein can slow down the damage to the kidney; however, protein is still needed for one’s overall health. Therefore, if you decide to start a low-protein diet, it is recommended to discuss this plan with a dietician, specifically one who specializes in diabetes and kidney disease, to ensure the right approach is taken [17].
Limit Salt in Your Diet
Diets high in salt can lead to elevated pressure, which in turn can lead to kidney damage. Therefore, it is important to limit the salt in your diet [17].
Avoid Medications that May Damage Your Kidneys
Do not take medications that may damage your kidneys, such as nonsteroidal anti-inflammatory drugs (NSAIDs), which include ibuprofen and naproxen. Also, be sure to discuss any supplements you are taking, as these may also lead to kidney damage [17].
Use Medications to Manage Diabetes that Also Are Renal Protectants
There are medications used to help manage diabetes, but they are also known to be kidney protectants. Two classes of medications that have been demonstrated to be kidney protectants include SGLT2 inhibitors, such as empagliflozin and canagliflozin, and GLP-1, such as semaglutide. Finerenone is another medication that people with diabetes can use to treat diabetes, but it also provides kidney protection. [6][11][17]
Dialysis
End-stage renal disease occurs when significant damage is done to the kidneys, and it is irreversible. Once you have end-stage renal disease, dialysis is used to treat it and is typically completed three times a week, with each session lasting 3-5 hours. The purpose of dialysis is to remove waste products and extra fluid from the blood and body since the kidneys are no longer able to do this on their own [4].
Self Quiz
Ask yourself...
- What is one class of medications that has been shown to be kidney protectant?
- What is one class of medications that should be avoided if you have kidney disease?
- At what stage of kidney disease does a person start dialysis?
- What are three ways to manage diabetic kidney disease?
- What are two methods to manage diabetes?
- How can hypertension lead to progression of diabetic kidney disease?
- What is the purpose of taking an ACE or ARB when diagnosed with diabetic kidney disease?
Research
A lot of research is emerging around managing diabetes, specifically how to preserve kidney function by slowing down the progression of kidney disease. A lot of the study is being tailored around medication management, specifically using medications initially approved to treat one chronic condition, such as hypertension or diabetes. Still, it can now be prescribed for patients starting to show a decline in kidney function. For example, blood pressure medications such as an ACE or ARB have an impact on the renin-angiotensin-aldosterone system (RAAS), and research is finding that if these medications are initiated after being diagnosed with type 2 diabetes, they can delay the onset or progression of diabetic kidney disease.
Another example is sodium-glucose cotransporter 2 (SGLT2) inhibitors, which initially were prescribed to treat type 2 diabetes and have been shown to decrease the risk of kidney disease in those with diabetes and cardiovascular disease [9].
Research also supports the idea that lifestyle modifications, such as blood sugar management, diet, exercise, and weight loss, can prevent or slow down the progression of diabetic kidney disease [8].
Ongoing research is continuing to find new therapies to treat and slow down the progression of diabetic kidney disease, which include stem cell therapy, gene therapy, and immunotherapy [9].
Conclusion
Diabetic kidney disease is becoming increasingly prevalent in the United States. As healthcare professionals, it is our responsibility to be competent in identifying those at risk of developing diabetic kidney disease, understand the appropriate diagnostic tests, and be prepared to educate our patients on the importance of managing their diabetes and the consequences of uncontrolled diabetes, such as diabetic kidney disease.
References + Disclaimer
- American Diabetes Association. (2024). Empower change during Hispanic heritage month. https://diabetes.org/?utm_source=google&utm_medium=paidsearch&utm_campaign=grants-fundraising-wefight&utm_content=responsive-search-ad&utm_term=awareness&gclid=Cj0KCQjwgL-3BhDnARIsAL6KZ6_MZYlxlYIvFXxtIFswm1TH0KtE4sEqh1NbD-WTRse2lowUgi_ibasaAqOJEALw_wcB
- American Diabetes Association. (2024). Extra weight extra risk. https://diabetes.org/health-wellness/weight-management/extra-weight-extra-risk
- American Heart Association. 2024, May 10). High blood pressure and your kidneys. https://www.heart.org/en/health-topics/high-blood-pressure/health-threats-from-high-blood-pressure/high-blood-pressure-and-your-kidneys
- American Kidney Fund. (2024, August 28). Stages of kidney disease (CKD). https://www.kidneyfund.org/all-about-kidneys/stages-kidney-disease
- American Kidney Fund. (2024, July 15). Signs and symptoms of kidney disease. https://www.kidneyfund.org/all-about-kidneys/signs-and-symptoms-kidney-disease?gad_source=1&gclid=Cj0KCQjwgL-3BhDnARIsAL6KZ69jH00MjCNBajDSEgW1hAqZXKrcu60f2VWv4zARP0S2waxJ2OhxzvIaAuncEALw_wcB
- American Kidney Fund. (2024, February 12). Glucagon-like peptide-1 receptor agonists (GLP-1 RAs). https://www.kidneyfund.org/treatments/medicines-kidney-disease/glp-1-ras
- Centers for Disease Control and Prevention. (2024, May 15). Diabetes basics. https://www.cdc.gov/diabetes/about/index.html
- Centers for Disease Control and Prevention. (2024, May 15). Testing for diabetes and prediabetes: A1C. https://www.cdc.gov/diabetes/diabetes-testing/prediabetes-a1c-test.html
- Elendu, C., John Okah, M., Fiemotongha, K.D.J., Adeyemo, B.I., Bassey, B.N., Omeludike, E.K., & Obidigbo, B. (2023). Comprehensive advancements in the prevention and treatment of diabetic nephropathy: A narrative review. Medicine (Baltimore)102 (40). doi: 10.1097/MD.0000000000035397
- Gembillo, G., Ingrasciotta, Y., Crisafulli, S., Luxi, N., Siligato, R., Santoro, D., & Trifirò, G. (2021). Kidney Disease in Diabetic Patients: From Pathophysiology to Pharmacological Aspects with a Focus on Therapeutic Inertia. International journal of molecular sciences, 22(9), 4824. https://doi.org/10.3390/ijms22094824
- Mayo Clinic. (2023, October 24). Diabetic nephropathy (kidney disease). https://www.mayoclinic.org/diseases-conditions/diabetic-nephropathy/diagnosis-treatment/drc-20354562
- Medline Plus. (2022, September 12). Microalbumin Creatinine Ratio. https://medlineplus.gov/lab-tests/microalbumin-creatinine-ratio/
- Mottl, A.K. & Tuttle, K.A. (2022, December 15). Diabetic kidney disease: Manifestations, evaluation, and diagnosis. UpToDate. https://www.uptodate.com/contents/diabetic-kidney-disease-manifestations-evaluation-and-diagnosis#H2332866574
- Mottl, A.K. & Tuttle, K.A. (2023, October 18). Diabetic kidney disease: Pathogenesis and epidemiology. UpToDate. https://www.uptodate.com/contents/diabetic-kidney-disease-pathogenesis-and-epidemiology#H3833541823
- National Institute of Diabetes and Digestive and Kidney Disease. (2016). Albuminuria: Albumin in the urine. https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/tests-diagnosis/albuminuria-albumin-urine#:~:text=Clinical%20Trials-,What%20is%20albuminuria%3F,the%20blood%20into%20the%20urine.
- National Institute of Diabetes and Digestive and Kidney Disease. (2014). Explaining your kidney test results: A tool for clinical use. https://www.niddk.nih.gov/health-information/professionals/advanced-search/explain-kidney-test-results
- National Kidney Foundation. (n.d.). Diabetes and kidney disease (stage 1-4). https://www.kidney.org/kidney-topics/diabetes-and-kidney-disease-stages-1-4
- The Cleveland Clinic. (2021, November 8). Diabesity: How obesity is related to diabetes. https://health.clevelandclinic.org/diabesity-the-connection-between-obesity-and-diabetes
Disclaimer:
Use of Course Content. The courses provided by NCC are based on industry knowledge and input from professional nurses, experts, practitioners, and other individuals and institutions. The information presented in this course is intended solely for the use of healthcare professionals taking this course, for credit, from NCC. The information is designed to assist healthcare professionals, including nurses, in addressing issues associated with healthcare. The information provided in this course is general in nature and is not designed to address any specific situation. This publication in no way absolves facilities of their responsibility for the appropriate orientation of healthcare professionals. Hospitals or other organizations using this publication as a part of their own orientation processes should review the contents of this publication to ensure accuracy and compliance before using this publication. Knowledge, procedures or insight gained from the Student in the course of taking classes provided by NCC may be used at the Student’s discretion during their course of work or otherwise in a professional capacity. The Student understands and agrees that NCC shall not be held liable for any acts, errors, advice or omissions provided by the Student based on knowledge or advice acquired by NCC. The Student is solely responsible for his/her own actions, even if information and/or education was acquired from a NCC course pertaining to that action or actions. By clicking “complete” you are agreeing to these terms of use.
➁ Complete Survey
Give us your thoughts and feedback
➂ Click Complete
To receive your certificate